Target Audience: Healthcare professionals, policymakers and community members.

Evidence-Based: The content is evidence-based as it draws on surveillance data and research from the health dept and CDC. Research supports the importance of data in improving outcomes for people with SCD (Piel et al., 2017, New England Journal of Medicine).

Application: Demonstrates how accurate data collection informs decision-making, funding, and targeted interventions.

DEI: Recognizes that SCD disproportionately affects African American and Hispanic populations and how data can assist in reducing health disparities.

Target Audience: Patients, families, and healthcare providers

Evidence-Based: While anecdotal, aligns with research on quality of life issues in SCD (Yawn et al., 2014, JAMA).

Application: Highlights real-world struggles with pain management, improving empathy, and informing clinical practice.

DEI: Elevates patient voices, particularly from marginalized communities.

Target audience: Parents, Caregivers, Healthcare workers

Evidence-Based: Though it is a personal experience, it reflects research findings on frequent hospitalizations in pediatric SCD (Kanter et al.,2020).

Application: Builds community support and validates patient experiences.

DEI: Highlights disparities in pediatric pain management.

Target Audience: Teens, Young adults, General Public

Evidence-Based: While not scholarly, it aligns with awareness goals supported by the CDC.

Application: Engages younger audiences and spreads awareness through viral content.

DEI: Provides a platform for minority youth to engage with health messaging.

Target Audience: General public and healthcare providers.

Evidence-Based: Maintained by CDC with peer-reviewed medical references.

Application: Comprehensive accessible info on SCD diagnosis, treatment, and management.

DEI: Addresses disparities in care and encourages equitable health access.

Target Audience: Patients and families exploring treatment advances.

Evidence-Based: Based on peer-reviewed clinical trials and FDA announcements.

Application: Informs decision-making about future treatment options.

DEI: Discusses access to gene therapy and equity in availability.

Target Audience: Patients, students, and caregivers seeking simple explanations.

Evidence-Based: NIH resources are peer-reviewed and accurate.

Application: Visualizes how red blood cells change shape, improving understanding for non-medical audiences.

DEI: Accessible design benefits diverse literacy levels.

Target Audience: Young adults and caregivers active on social media.

Evidence-Based: Sickle Cell 101 is a nonprofit organization that shares content supported by CDC and NIH guidelines.

Application: Raises awareness of the importance of newborn screening and preventative care.

DEI: Uses culturally relevant language and imagery to reach minority communities most affected.